Study of Ramucirumab in Ovarian Cancer

Clinical trial NCT00721162 · COMPLETED

Trial details

NCT number: NCT00721162
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2008-08-01
Primary completion: 2012-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.